Strategic Partnerships MMV maintains a broad collaboration network with over 375 partners across pharmaceutical, academic, and endemic-country organizations in 50 countries, presenting a strong entry point for joint grant proposals, co-development programs, and access to endemic markets.

Nonprofit R&D Funding As a nonprofit product development partnership focused on antimalarials with a revenue range of 10-25 million, MMV seeks collaborations and funding opportunities with donors, philanthropic foundations, and public-sector partners to scale drug discovery, clinical trials, and access initiatives.

AI Drug Discovery MMV is actively pursuing AI driven drug discovery and digital health tools, including the dd4gh platform, offering opportunities to supply AI chemistry services, data partnerships, and technology licenses that accelerate malaria drug development.

Public Health Impact Recent milestones include tackling drug quality and counterfeit issues in Africa and deploying novel cures, indicating opportunities to position products or services around quality assurance, pharmacovigilance, regulatory support, and health systems strengthening.

Global Outreach With operations spanning global health events and partnerships with organizations like GARDP, DNDi, and GSK, there is scope to offer capacity building, training programs, and regional implementation support to improve research efficiency and market access in endemic regions.